These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34080170)

  • 1. A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19.
    Mehrpour M; Arab M; Hadavand F; Khalafi M; Khalafi M
    Acta Neurol Belg; 2021 Aug; 121(4):1079-1080. PubMed ID: 34080170
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2-related Guillain-Barré syndrome requires comprehensive diagnostic and therapeutic care.
    Finsterer J
    J Med Life; 2024 Jan; 17(1):126. PubMed ID: 38737653
    [No Abstract]   [Full Text] [Related]  

  • 3. First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome.
    Araújo NM; Ferreira LC; Dantas DP; Silva DS; Dos Santos CA; Cipolotti R; Martins-Filho PR
    Pediatr Infect Dis J; 2021 Jul; 40(7):e274-e276. PubMed ID: 33990525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-related Guillain-Barré syndrome requires comprehensive diagnostic and therapeutic care.
    Abdelazim I; Donayeva A; Mannapova A
    J Med Life; 2024 Jan; 17(1):127-128. PubMed ID: 38737664
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.
    Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ
    Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study.
    Saini L; Krishna D; Gunasekaran PK; Tiwari S; Kumar P; Goyal JP; Khera D; Choudhary B; Didel S; Gaur R; Laxmi V; Panda S; Singh K
    J Child Neurol; 2023 May; 38(6-7):407-413. PubMed ID: 37365810
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Paediatric Patients.
    Mehri S; Zarrouk S; Finsterer J
    Sultan Qaboos Univ Med J; 2023 Nov; 23(4):566-568. PubMed ID: 38090231
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: A relapse of Guillain-Barre syndrome caused by SARS-CoV-2 is not uncommon.
    Mehri S; Finsterer J; Jankovic VS
    Neurosciences (Riyadh); 2024 Jan; 29(1):65-66. PubMed ID: 38195132
    [No Abstract]   [Full Text] [Related]  

  • 9. Affection of Cranial Nerves in COVID-19 Patients Should Prompt Suspicion of Guillain-Barre Syndrome.
    Finsterer J; Scorza FA
    Eur Neurol; 2022; 85(3):208-209. PubMed ID: 35066502
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry.
    Lucchese G; Flöel A
    Brain; 2021 Jun; 144(5):e43. PubMed ID: 33822012
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation between COVID-19 and Guillain-Barre syndrome in adults. Systematic review.
    Araya-Quintanilla F; Valdés-Orrego I; Gutiérrez-Espinoza H
    Neurologia (Engl Ed); 2021 Mar; 36(2):183-184. PubMed ID: 33139091
    [No Abstract]   [Full Text] [Related]  

  • 12. Unclear association between COVID-19 and Guillain-Barré syndrome.
    Vogrig A; Moritz CP; Camdessanché JP; Tholance Y; Antoine JC; Honnorat J; Gigli GL
    Brain; 2021 Jun; 144(5):e45. PubMed ID: 33755098
    [No Abstract]   [Full Text] [Related]  

  • 13. Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome.
    Foschi M; D'Anna L; Abdelhak A; Mayer B; Tumani H; Otto M; Abu-Rumeileh S
    Brain; 2021 Jun; 144(5):e44. PubMed ID: 33822000
    [No Abstract]   [Full Text] [Related]  

  • 14. Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Amato A
    Neurology; 2021 Oct; 97(17):841-842. PubMed ID: 34697214
    [No Abstract]   [Full Text] [Related]  

  • 15. Reader Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Willer J
    Neurology; 2021 Oct; 97(17):841. PubMed ID: 34697213
    [No Abstract]   [Full Text] [Related]  

  • 16. On "Guillain-Barré Syndrome Related and Unrelated to COVID-19: Clinical Follow-Up in the COVID-19 Era." Masuccio FG, Tipa V, Invernizzi M, Solaro C. Phys Ther. 2022; 102:pzac049. https://doi.org/10.1093/ptj/pzac049.
    Finsterer J
    Phys Ther; 2022 Nov; 102(11):. PubMed ID: 36168885
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there an association between COVID-19 infection and fetuses with mirror-image dextrocardia?
    Xu W; Wei Y; Huo H; Zhao E; Liu B
    Arch Gynecol Obstet; 2024 Aug; 310(2):1279-1281. PubMed ID: 38443582
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent GBS With COVID-19 in a Child: A Case Report.
    Akçay N; Oğur M; Menentoglu ME; Sofuoğlu Aİ; Işik İ; Şevketoğlu E
    Pediatr Infect Dis J; 2023 Apr; 42(4):e129-e130. PubMed ID: 36728988
    [No Abstract]   [Full Text] [Related]  

  • 19. Guillain-Barré syndrome following severe COVID-19 directly after kidney transplantation.
    Szczygieł A; Logoń K; Poznański P; Koszewicz M; Krajewska M; Kamińska D
    Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 36994916
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials.
    Finsterer J
    J Med Virol; 2021 Oct; 93(10):5687-5688. PubMed ID: 34081332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.